As of 2024-12-15, the Relative Valuation of Tissue Regenix Group PLC (TRX.L) is (37.48) GBP. This relative valuation is based on P/E multiples. With the latest stock price at 58.00 GBP, the upside of Tissue Regenix Group PLC based on Relative Valuation is -164.6%.
The range of the Relative Valuation is (34.68) - (39.60) GBP.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 22.4x - 40.4x | 29.4x |
| Forward P/E multiples | 16.3x - 25.6x | 19.1x |
| Fair Price | (34.68) - (39.60) | (37.48) |
| Upside | -159.8% - -168.3% | -164.6% |
| Date | P/E |
| 2024-12-13 | -37.53 |
| 2024-12-12 | -37.53 |
| 2024-12-11 | -36.88 |
| 2024-12-10 | -37.53 |
| 2024-12-09 | -36.88 |
| 2024-12-06 | -37.53 |
| 2024-12-05 | -37.53 |
| 2024-12-04 | -37.53 |
| 2024-12-03 | -37.53 |
| 2024-12-02 | -37.53 |
| 2024-11-29 | -37.20 |
| 2024-11-28 | -37.20 |
| 2024-11-27 | -37.20 |
| 2024-11-26 | -36.88 |
| 2024-11-25 | -36.88 |
| 2024-11-22 | -36.88 |
| 2024-11-21 | -37.20 |
| 2024-11-20 | -38.17 |
| 2024-11-19 | -38.82 |
| 2024-11-18 | -39.47 |
| 2024-11-15 | -39.47 |
| 2024-11-14 | -39.79 |
| 2024-11-13 | -40.11 |
| 2024-11-12 | -40.11 |
| 2024-11-11 | -40.11 |
| 2024-11-08 | -39.60 |
| 2024-11-07 | -40.11 |
| 2024-11-06 | -39.47 |
| 2024-11-05 | -39.47 |
| 2024-11-04 | -39.14 |
| 2024-11-01 | -39.47 |
| 2024-10-31 | -38.50 |
| 2024-10-30 | -37.20 |
| 2024-10-29 | -35.26 |
| 2024-10-28 | -34.29 |
| 2024-10-25 | -34.94 |
| 2024-10-24 | -34.94 |
| 2024-10-23 | -34.94 |
| 2024-10-22 | -34.94 |
| 2024-10-21 | -34.94 |
| 2024-10-18 | -34.94 |
| 2024-10-17 | -34.94 |
| 2024-10-16 | -34.94 |
| 2024-10-15 | -34.94 |
| 2024-10-14 | -34.94 |
| 2024-10-11 | -34.94 |
| 2024-10-10 | -34.94 |
| 2024-10-09 | -34.94 |
| 2024-10-08 | -34.94 |
| 2024-10-07 | -34.94 |